Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population
| Status: | Recruiting |
|---|---|
| Conditions: | Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - 39 |
| Updated: | 2/21/2019 |
| Start Date: | May 31, 2017 |
| End Date: | June 2020 |
The purpose of this study is to develop and test a model of patient navigation that
investigators hope will address the unique needs of adolescent and young adult (AYA) cancer
patients and their families by minimizing barriers in their care and potentially improving
the outcomes of their treatment while reducing distress and enhancing quality of life.
Investigators plan to achieve this by increasing access to, and use of, the resources
available at Moffitt Cancer Center for AYA patients and their families.
investigators hope will address the unique needs of adolescent and young adult (AYA) cancer
patients and their families by minimizing barriers in their care and potentially improving
the outcomes of their treatment while reducing distress and enhancing quality of life.
Investigators plan to achieve this by increasing access to, and use of, the resources
available at Moffitt Cancer Center for AYA patients and their families.
Up to 80 participants may be recruited to this study at Moffitt Cancer Center to obtain a
final sample size of 60 completed participants.
Participants will be identified in consultation with the patient's primary oncologist and
program social worker. A research assistant (RA) will verify eligibility and consent eligible
patients.
After completing a baseline questionnaire, participants will be randomly placed into one of
two groups. Both groups will receive their normal care, but one group will also meet with a
patient navigator. Participants in both groups will be asked to complete a follow-up
questionnaire approximately 8 to 10 weeks from when they complete the baseline questionnaire.
The follow-up questionnaire will take about 15 to 20 minutes to complete.
Participation in the study will last about 10 weeks.
final sample size of 60 completed participants.
Participants will be identified in consultation with the patient's primary oncologist and
program social worker. A research assistant (RA) will verify eligibility and consent eligible
patients.
After completing a baseline questionnaire, participants will be randomly placed into one of
two groups. Both groups will receive their normal care, but one group will also meet with a
patient navigator. Participants in both groups will be asked to complete a follow-up
questionnaire approximately 8 to 10 weeks from when they complete the baseline questionnaire.
The follow-up questionnaire will take about 15 to 20 minutes to complete.
Participation in the study will last about 10 weeks.
Inclusion Criteria:
- Patients 18 to 39 years old.
- Will undergo chemotherapy and/or radiotherapy and/or surgery with no plans to undergo
a transplant procedure within the next 3 months.
- Have no previous cancer history other than non-melanoma skin cancer.
- Able to speak and read English.
- Able to provide written informed consent.
Exclusion Criteria:
- Does not meet any of the Inclusion Criteria.
We found this trial at
1
site
12902 USF Magnolia Dr
Tampa, Florida 33612
Tampa, Florida 33612
(888) 663-3488
Principal Investigator: Kristine Donovan, PhD, MBA
Phone: 813-745-8562
H. Lee Moffitt Cancer Center & Research Institute Moffitt Cancer Center in Tampa, Florida, has...
Click here to add this to my saved trials
